Clin Osteol 2010; 15(1): 9-17

Longitudinal study of bone mineral density changes in patients with systemic lupus erythematosusOriginal contributions

M. ®urek, P. Horák, A. Smrľová, M. Skácelová

Keywords: systémový lupus erytematodes, osteoporóza v SUMMARY

Published: June 11, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
®urek M, Horák P, Smrľová A, Skácelová M. Longitudinal study of bone mineral density changes in patients with systemic lupus erythematosus. Osteologický bulletin. 2010;15(1):9-17.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of fe and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001;28:525-532.
    2. Georges C, Chassany O, Mouthon L et al. Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis. Rev Med Interne 2004;25:16-21. Go to original source...
    3. Harris-Love MO. Physical activity and disablement in the idiopathic inflammato­ ry myopathies. Curr Opin Rheumatol 2003;15:679-690. Go to original source...
    4. Merrel M, Shulman LE. Determination of prognosis in chronic disease, illustra by systemic lupus erythematosus. J Chronic Dis 1955;1:12-32. Go to original source...
    5. Abu-Shakra M, Urowitz MB, Gladman DD et al. Mortality studies in systemic lu­ pus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol 1995;22:1259-1264.
    6. Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus erythe­ matosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum 1970;13:802-811. Go to original source...
    7. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, preva ce, outcome, and first symptoms; the high prevalence in black women. Arch Int Med 1974;134:1027-1035. Go to original source...
    8. Michet CJ, McKenna CH, Elveback LR et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, through 1979. Mayo Clin Proc 1985;60:105-113. Go to original source...
    9. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum 1985;28:80-86. Go to original source...
    10. McCarty DJ, Manzi S, Medsger TA et al. Incidence of systemic lupus erythe tosus. Race and gender differences. Arthritis Rheum 1995;38:1260-1270. Go to original source...
    11. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 1973;3:1-54. Go to original source...
    12. Acers TE, Acers-Warn A. Incidence patterns of immunogeneti North American Indians. J Okla State Med Assoc1994;87:309-314.
    13. Atkins C, Reuffel L, Roddy J et al. Rheumatic disease in the Nuu-Chah-Nulth tive Indians of the Pacific Northwest. J Rheumatol 1988;15:684-690.
    14. Becker A, Fischer R, Schneider M. Bone density and 25-OH vitamin D serum le­ vel in patients with systemic lupus erythematosus. Z Rheumatol 2001; 60:352-358. Go to original source...
    15. Huisman AM, White KP, Algra A, Harth M et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001;28:2535-2539.
    16. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classific of systemic lupus erythematosus. Arthrit Rheum 1982;25:1271-1277. Go to original source...
    17. f^soto SG, Mendonca BB, Bonfa E. Menstrual disturbances in patients with sys­ temic lupus erythematosus without alkylating therapy: clinical, hormonal and the­ rapeutic associations. Lupus 2002;11:175-180. Go to original source...
    18. Wang CL, Wang F, Bosco JJ. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus 1995;4:11-14. Go to original source...
    19. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J et al. Elevated levels nous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991;147:117-123. Go to original source...
    20. Al-Janadi M, Al-Balla S, Al-Dalaan A et al. Cytokine role in systemic lupus er hematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993;13:58-67. Go to original source...
    21. Tahala Y, Watanabe K, Suzuki M et al. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol 1989;9:415^20. Go to original source...
    22. Star VL, Hochberg MC. Osteoporosis in patients with rheumatic diseases. Rheum Dis Clin N Am 1994;20:561-576. Go to original source...
    23. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A di­ sease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-640. Go to original source...
    24. Brunner HI, Silverman ED, Bombardier C et al. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-on­ set systemic lupus erythematosus. Arthritis Rheum 2003;49:335-341. Go to original source...
    25. Gladman D, Ginzler E, Goldsmith Ch et al. The development and initial val on of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis & Rheumatism 1995;38:363-369. Go to original source...
    26. World Health Organization. Assessment of fracture risk and its application to reening for postmenopausal osteoporosis. Geneva, Switzerland: WHO; 1994.
    27. Formiga F, Moga I, Nolla JM et al. Loss of bone mineral density in premenopau­ sal women with systemic lupus erythematosus. Ann Rheum Dis; 1995;54:274-276. Go to original source...
    28. Sinigaglia L, Varenna M, Binelli L et al. Determinants ofbone mass in systemic pus erythematosus: a cross sectional study on premenopausal women. J Rheumatol 1999;26:1280-1284.
    29. Mok CC, Mak A, Ma KM et al. Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus. Lupus 2005;14:106-112. Go to original source...
    30. Chen CJ, Yen JH, Tsai WC et al. Decreased bone mineral density in premenopau­ sal patients with systemic lupus erythematosus. Kaohsiung J Med Sci 1996;12:567-572.
    31. Uaratanawong S, Deesomchoke U, Lertmaharit S et al. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 2003;30:2365-2368.
    32. Lee C, Almagor O, Dunlop DD. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 2006;45:53-60. Go to original source...
    33. Teichman J, Lange U, Federlin K et al. Bone metabolism and bone mineral densi­ ty of systemic lupus erytematosus at the time of diagnosis Rheumatol Int 1999;18: 137-140. Go to original source...
    34. Bhattoa HP, Kiss E, Bettembuk P et al. Bone mineral density, biochemical mar­ kers of bone turnover, and hormonal status in men with SLE. Rheumatol Int 2001;21:97-102. Go to original source...
    35. Mok1 CC, Ying SK, To CH et al. Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone 2008;43:327-331.
    36. Li EK, Tam LS, Young RP et al. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 1998;37:405^10. Go to original source...
    37. Matsuyama T, Ishii S, Tokita A et al. Vitamin D receptor genotypes and bone mi­ neral density. Lancet 1995;345:1238-1239. Go to original source...
    38. Young RP, Lau EMC, Birjandi Z, Critchley JAJH et al. Interethnic differences in hip fracture rate and the Vitamin D receptor polymorphism. Lancet 1996;348: 688-689. Go to original source...
    39. Houssiau FA, Lefebvre C, Depresseux et al. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996;35:244-247. Go to original source...
    40. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheu­ matoid arthritis: a review. Br J Rheumatol 1996;35:309-322. Go to original source...
    41. Haugeberg G, Uhlig T, Falch JA et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 39 in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000;43: 522-530. Go to original source...
    42. Lodder MC, de Jong Z, Kostense PJ et al. Bone mineral density in patients with rheumatoid arthritis: relation between sity. Ann Rheum Dis 2004;63:1576-1580. Go to original source...
    43. Gilboe IM, Kvien TK, Haugeberg G, Husby G. Bone mineral density in systemic lupus erythematosus: compariso Ann Rheum Dis 2000;59:110-115. Go to original source...
    44. Formiga F, Moga I, Navarro MA et al. Bone mineral density in female patie with systemic lupus erythematosus treated with high glucocorticoid doses. Rev Clin Esp 1996;11:747-750.
    45. Pons F, Peris P, Guanabens N et al. The effect of systemic lupus ery and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-746. Go to original source...
    46. Hansen M, Halberg P, Kollerup G et al. Bone metabolism in patients with syste­ mic lupus erythematosus. Effect of Scand J Rheumatol 1998;27:197-206. Go to original source...
    47. Jardinet D, Lefebvre C, Depresseux, G et al. Longitudinal analysis of bone ral density in pre-menopausal female systemic lupus erythematosus patients: de­ leterious role of glucocorticoid therapy at the lumbar spine. Rheumatology (Oxford) 2000;39:389-392. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.